Access the full text.
Sign up today, get DeepDyve free for 14 days.
Brigitte Dietz, H. Klose, L. Gürtler, J. Eberle, F. Deinhardt, Katalin Köhler-Vajta, P. Peller (1986)
Correlation of Antibodies to LAV/HTLV III in Hemophiliacs with the Use of Virus-Inactivated Clotting FactorsThrombosis and Haemostasis, 56
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
G. Siegl, R. Bates, K. Berns, B. Carter, D. Kelly, E. Kurstak, P. Tattersall (1985)
Characteristics and taxonomy of Parvoviridae.Intervirology, 23 2
M. Stirling, J. Murray, P. Mackay, S. Black, J. Peutherer, C. Ludlam (1983)
Incidence of infection with hepatitis B virus in 56 patients with haemophilia A 1971-1979.Journal of Clinical Pathology, 36
M. Anderson, L. Davis, J. Hodgson, S. Jones, L. Murtaza, J. Pattison, C. Stroud, J. White (1982)
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period.Journal of Clinical Pathology, 35
J. Craske, P. Kirk, B. Cohen, E. Vandervelde (1978)
Commercial factor VIII associated hepatitis, 1974–75, in the United Kingdom: a retrospective surveyJournal of Hygiene, 80
B. Cohen, M. Buckley (1988)
The prevalence of antibody to human parvovirus B19 in England and Wales.Journal of medical microbiology, 25 2
J. Shneerson, P. Mortimer, E. Vandervelde (1980)
Febrile illness due to a parvovirus.British Medical Journal, 280
Y. Cossart, B. Cant, A. Field, D. Widdows (1975)
PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 305
M. Melbye, R. Madhok, P. Sarin, G. Lowe, J. Goedert, K. Froebel, R. Biggar, S. Stenbjerg, C. Forbes, R. Gallo, P. Ebbesen (1984)
HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USAThe Lancet, 324
J. Kelleher, N. Luban, P. Mortimer, T. Kamimura (1983)
Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis.The Journal of pediatrics, 102 5
O. Corsi, A. Azzi, M. Morfini, R. Fanci, P. Ferrini (1988)
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 25
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
Clewley Jp (1985)
Detection of human parvovirus using a molecularly cloned probe.Journal of Medical Virology, 15
M. Anderson, E. Lewis, I. Kidd, S. Hall, B. Cohen (1984)
An outbreak of erythema infectiosum associated with human parvovirus infectionJournal of Hygiene, 93
J. Levy, G. Mitra, M. Wong, M. Mozen (1985)
INACTIVATION BY WET AND DRY HEAT OF AIDS-ASSOCIATED RETROVIRUSES DURING FACTOR VIII PURIFICATION FROM PLASMAThe Lancet, 325
Meeting of experts on the utilization and supply of human blood and blood products . WHO Lab / 76 . 2 society transactions
B. Cohen, P. Mortimer, M. Pereira (1983)
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV)Journal of Hygiene, 91
M. Lederman, O. Ratnoff, B. Evatt, J. Mcdougal (1985)
Acquisition of antibody to lymphadenopathy-associated virus in patients with classic hemophilia (factor VIII deficiency).Annals of internal medicine, 102 6
R. Enck, R. Betts, M. Brown, G. Miller (1979)
Viral Serology (Hepatitis B Virus, Cytomegalovirus, Epstein‐Barr Virus) and Abnormal Liver Function Tests in Transfused Patients with Hereditary Hemorrhagic DiseasesTransfusion, 19
S. Salahuddin, P. Markham, R. Redfield, M. Essex, J. Groopman, M. Sarngadharan, M. McLane, A. Sliski, R. Gallo (1984)
HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONSThe Lancet, 324
Abstract. The prevalence of antibody to human parvovirus B19 was determined in 86 children with congenital bleeding disorders. Forty‐seven of 53 boys (89%) receiving non‐heat‐treated factor VIII or prothrombin complex concentrates were anti‐B19 IgG positive compared with 38% of their age‐matched controls and 48% of children treated with cryoprecipitate. Acute B19 virus infection occurred in 2 boys 3–4 weeks after they had received the same batch of commercial factor VIII concentrate. Of 11 susceptible children who had only received heat‐treated National Health Service factor VIII concentrate (8Y), I acquired anti‐B19 IgG. This suggests that 8Y heat‐treated concentrate has a much reduced risk of transmitting B19 virus and, by implication, other less heat‐stable viruses such as human immunodeficiency virus.
Vox Sanguinis – Wiley
Published: Apr 1, 1990
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.